You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 774 NeoPOWER: A phase II study of neoadjuvant PD-1 blockade with cemiplimab in high risk localized, locally recurrent and regionally advanced cutaneous squamous cell carcinoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
774 NeoPOWER: A phase II study of neoadjuvant PD-1 blockade with cemiplimab in high risk localized, locally recurrent and regionally advanced cutaneous squamous cell carcinoma

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023260016
Dec 20238004
Jan 20244103
Feb 20245005
Mar 20246809
Apr 202410408
May 20244003
Jun 20249808
Jul 20246807
Aug 20243203
Sep 20243803
Oct 20244606
Nov 20249207
Dec 20244007
Jan 20254106
Feb 20251207
Mar 2025004
Apr 2025005
May 2025108
Jun 2025004
Total11110123